🔎 Trials Near Me

Home › Kanser sa Baga › Ohio › Akron

Pag-aaral pangklinika para sa Kanser sa Baga sa Akron, OH

16 pag-aaral para sa Kanser sa Baga ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Akron (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Nagre-recruitPhase 3
  • Cleveland Clinic Akron General, Akron
  • Aultman Health Foundation, Canton · 21 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Summa Health System - Akron Campus, Akron
  • Cleveland Clinic Akron General, Akron
  • Summa Health System - Barberton Campus, Barberton · 7 mi ang layo
  • at 1 pa
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Nagre-recruitPhase 3
  • Aultman Health Foundation, Canton · 21 mi ang layo
Edad 70 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06096844

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Nagre-recruitPhase 3
  • Aultman Health Foundation, Canton · 21 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06498635

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]

Nagre-recruitPhase 3
  • GSK Investigational Site, Canton · 21 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07099898

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Nagre-recruitPhase 3
  • Aultman North, North Canton · 15 mi ang layo
  • Aultman Massillon, Massillon · 20 mi ang layo
  • Aultman Orrville Hospital, Orrville · 21 mi ang layo
  • at 2 pa
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07222566

A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

Nagre-recruitPhase 1/2
  • GSK Investigational Site, Canton · 21 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07602855

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Nagre-recruitPhase 2/3
  • Gabrail Cancer Center Research, Canton · 21 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06712316

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Nagre-recruitPhase 3
  • Cleveland Clinic - Akron General Hematology & Oncology, Akron
  • Cleveland Clinic Mercy Hospital Cancer Center, Canton · 21 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06712355

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Nagre-recruitPhase 3
  • Cleveland Clinic Akron General, Akron
  • Cleveland Clinic Mercy Hospital, Canton · 21 mi ang layo
  • Aultman Health Foundation, Canton · 21 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05624996

Integrated Cancer Repository for Cancer Research

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Aultman Hospital, Canton · 21 mi ang layo
  • Aultman Alliance Community Hospital, Alliance · 24 mi ang layo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Nagre-recruitPhase 2
  • Cleveland Clinic Mercy Hospital, Canton · 21 mi ang layo
  • Aultman Health Foundation, Canton · 21 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2
  • Aultman Health Foundation, Canton · 21 mi ang layo
18 Minutes · Lahat ng kasarian · Na-update May 5, 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2/3
  • Aultman Health Foundation, Canton · 21 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT06616584

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Nagre-recruitObservasyonal na pag-aaral
  • Tri-County Hematology & Oncology Associates, Inc., Massillon · 20 mi ang layo
  • Cleveland Clinic Mercy Hospital, Canton · 21 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 23, 2026 · NCT05974150

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

Nagre-recruitPhase 1/2
  • Gabrail Cancer Center Research, Canton · 21 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 24, 2025 · NCT06228326

Pag-aaral para sa Kanser sa Baga sa ibang lungsod

Iba pang pag-aaral sa Akron

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.